YI
111, Inc.
YI Q2 2026 earnings
Published Sep 17, 2026
AI summary
- Revenue $339M, down 28% from $472M a year ago.
- Adjusted EPS −$0.60, down from −$0.27 a year ago.
- Net revenue fell 28.3% year-over-year to $339 million as the company shifts to an asset-light business model.
- The company reported a net loss of $4.7 million, compared to a $1.1 million loss in the prior-year quarter.
- Promotional product revenue grew 121% year-over-year, driven by strong sales of key pharmaceutical offerings.
Results vs analyst consensus
Revenue
Reported
$339M
Consensus not captured before release
−28% YoY
Adjusted EPS
Reported · Non-GAAP loss per ADS
−$0.60
Consensus not captured before release
GAAP EPS: −$0.60
Consensus: Yahoo Finance · Q2 2026
Revenue display rounded; difference uses exact result.
Next quarter outlook
No guidance in this release.
What to watch
- The company incurred significant severance costs this quarter related to workforce streamlining.
- The company is managing ongoing redemption obligations to investors of 1 Pharmacy Technology.
Read original report
Source: 111, Inc. press release · SEC Form 6-K exhibit 99.1